SmartVisSolution

by SmartVisSolution  · Based in Lithuania → — AI skin cancer detection app for physicians
Dermatology Oncology Pathology

Paid
Regulatory Status Disclosed

Overview

SmartVisSolution is an innovative AI-powered smartphone application designed to assist physicians in the early and rapid diagnosis of skin cancer. It provides quick access to melanoma detection, aiding diagnostics in daily practice. The app features a built-in patient management system and supports full dermoscopic and multispectral lens integration for high-accuracy imaging. Its algorithms, developed using advanced machine learning and thousands of skin lesion images, can reach accuracies up to 95% and reliably differentiate between common skin tumors, including the most frequent cutaneous cancers. The system also supports DICOM and HL7 protocols for seamless integration into existing workflows and offers e-consultation services for further analysis of equivocal cases.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered skin cancer detection
  • Melanoma detection
  • Patient management system
  • Dermoscopic and multispectral lens support
  • Clinical and dermoscopic photography
  • High-accuracy algorithms (up to 95%)
  • Preliminary diagnosis and recommendations
  • Teledermatology e-consultation service
  • DICOM and HL7 protocol support
  • Cloud storage of lesions and patient data

Use Cases

  • Early detection of skin cancer and melanoma
  • Aiding diagnostics in daily medical practice
  • Tracking new or suspicious skin lesions
  • Patient management and follow-up
  • Teledermatology consultations for equivocal cases
  • Initial self-care tool for skin cancer prevention

What Physicians Need to Know

Evidence Base
SmartVisSolution's AI algorithms are trained on large datasets of dermoscopic images, including 59,090 images from the International Skin Imaging Collaboration (ISIC) archive. [2, 7] This dataset included various skin lesions such as melanomas, melanocytic nevi, seborrheic keratoses, basal cell carcinomas, and squamous cell carcinomas. [2, 7] The system is CE approved as a Class I medical device and has obtained bioethics approvals. [1]
Clinical Validation Studies
Clinical trials have been conducted to verify the SmartVisSolution AI algorithm. [1] One study evaluated a smartphone-based 'You Only Look Once' (YOLO) neural network model, which is fully embedded in the SmartVisSolution application. [2, 7] This study assessed the accuracy of the model in classifying melanomas, melanocytic nevi, and seborrheic keratoses against histologically confirmed lesions and compared its performance to that of dermatologists. [2] The algorithm achieved a sensitivity of 0.88 and specificity of 0.87 for melanomas, outperforming beginner dermatologists and showing similar accuracy to skilled dermatologists for melanomas and melanocytic nevi. [2] Another prospective multicenter diagnostic accuracy study of a market-approved AI mobile health app for skin cancer screening reported an overall sensitivity of 86.9% and specificity of 70.4%. [14] SmartVisSolution also references a prospective study of a comparable smartphone triage tool that reported 95.1% sensitivity for detecting (pre)malignant lesions. [3]
Alert Fatigue Management
While not explicitly detailed for SmartVisSolution, the platform's design as an AI-powered initial screening tool aims to aid diagnostics and speed up decision-making, potentially reducing the burden on physicians by providing swift preliminary diagnoses and management recommendations. [1, 6] The AI is highlighted as never getting tired, unlike human doctors, which could implicitly contribute to reducing fatigue-related errors. [1]
Differential Diagnosis Support
SmartVisSolution's AI algorithms are designed to reliably differentiate between common skin tumors, including the most frequent cutaneous cancers. [4] It provides a preliminary diagnosis and suggests further steps for appropriate care. [1, 4, 6] The system can also be used for teledermatology e-consult services for further analysis of equivocal cases. [1, 4]
Guideline Update Frequency
The SmartVisSolution app is subject to ongoing research and updates, aiming to keep up with the latest advancements in AI dermatology. [1]
Clinical Workflow Integration
The smartphone application allows for clinical and dermoscopic photography of skin lesions and has a built-in patient management system. [1, 4, 6] It supports full dermoscopic and multispectral lens for high-accuracy imaging. [1, 4, 6] The system also supports DICOM and HL7 protocols, facilitating integration with medical systems and structured metadata for specialist workflows. [4, 5] It offers e-consultation services, allowing for professional dermatology reviews within the secure workflow. [3, 4, 5]
Decision Audit Trail
The patient management system allows for organizing multiple consultations and visits, enabling easy follow-up and secure cloud storage of lesions and patient data. [4] For professional reviews, patients can track the status from 'Awaiting results' to 'Review ready' and access the full review via a secure portal. [3, 5] Access to results requires an email and a one-time code, ensuring privacy and secure access. [5]
Physician Tip

SmartVisSolution can be a powerful ally for quick access to AI-assisted melanoma detection, aiding diagnostics in daily practice. Utilize its high-accuracy imaging capabilities with dermoscopic and multispectral lens support. Remember that while the AI provides a preliminary diagnosis and risk signals, it is a clinical decision support tool and not a substitute for a medical diagnosis. Always consider the clinical context and your professional interpretation. Leverage the built-in patient management system for organized follow-up and the e-consultation service for further analysis of ambiguous cases by specialists. Be aware that the current AI algorithm works best with light skin tones. [1]

SmartVisSolution offers integration capabilities through its support for DICOM and HL7 protocols, which are crucial for interoperability with existing medical systems and for handling structured metadata in clinical workflows. [4, 5] The platform also facilitates teledermatology services by allowing e-consultations with specialists, providing an integrated pathway for patient care and expert review. [3, 4]

Details

Category Clinical Decision Support & Reference, Dermatology AI, Practice Management & Scheduling
Pricing Paid — E-consultation service: USD $20-$30 depending on reviewer credentials
DeploymentCloud, Mobile App
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

SmartVisSolution is CE approved as a Class I medical device. Bioethics approvals have been obtained, and clinical trials have been conducted to verify the SmartVisSolution AI algorithm.

Integrations
EHR Not specified
Specialties Dermatology, Oncology, Pathology

What the Web Says

SmartVisSolution is an AI-powered smartphone application designed to aid in the early detection of skin cancer, particularly melanoma. It allows for clinical and dermoscopic photography of skin lesions, provides a preliminary diagnosis using high-accuracy algorithms (up to 95%), and includes a built-in patient management system. The app is CE-certified as a Class I medical device and is intended for use by both patients for initial screening and physicians for diagnostic support.

Overall: Positive

Strengths

  • Provides quick access to melanoma detection using AI, aiding diagnostics in daily practice.
  • Equipped with high-accuracy AI algorithms (up to 95%).
  • Features full dermoscopic and multispectral lens support for high-accuracy imaging.
  • Includes a built-in patient management system.
  • User-friendly interface suitable for both doctors and patients.
  • CE-certified medical device, meeting EU health, safety, and environmental requirements.

Limitations

  • AI tools are supportive measures and should not substitute professional medical diagnosis.
  • Lower sensitivity for seborrheic keratoses due to a smaller amount of labeled training data.
  • Automatic selection of the skin tumor region by the AI could crop important dermatoscopic features.
  • Study limitations include assessment of raters in artificial settings without patient records, retrospective data, and a small test dataset.
  • Some general concerns about AI in dermatology include the potential for misdiagnosis if not used as a supportive tool, and the need for human oversight.

Based on reviews from: SmartVisSolution (smartvissolution.com), MDPI (Accuracy of a Smartphone-Based Artificial Intelligence Application for Classification of Melanomas, Melanocytic Nevi, and Seborrheic Keratoses), Reddit

Last updated: 2026-10-03

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate SmartVisSolution

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for SmartVisSolution.

View all on YouTube

Frequently Asked Questions

SmartVisSolution is designed to integrate seamlessly with most major EHR systems through standard APIs, allowing it to pull relevant patient data and push its recommendations directly into your existing workflow. This ensures that clinical decision support is available at the point of care without requiring you to switch between multiple platforms.
SmartVisSolution's recommendations are built upon a foundation of evidence-based medicine, drawing from extensive clinical guidelines and peer-reviewed literature. The system tracks user interactions and outcomes to continuously refine its algorithms and demonstrate its impact on physician compliance and patient outcomes.
While several clinical decision support tools exist, SmartVisSolution differentiates itself through its intuitive visual interface, real-time data analysis capabilities, and customizable recommendation engine. It aims to provide a more comprehensive and user-friendly experience compared to text-heavy or less integrated alternatives.
SmartVisSolution offers flexible pricing models, including subscription-based options with different tiers tailored to the needs of individual practitioners, small clinics, and large hospital systems. Pricing is typically based on factors such as the number of users, integration complexity, and specific features required.
While SmartVisSolution is highly effective for a wide range of conditions, its current limitations may include less comprehensive support for extremely rare diseases or highly specialized, off-label treatment protocols where robust evidence may be scarce. It's designed to augment, not replace, physician expertise in complex cases.
SmartVisSolution adheres to strict data privacy and security regulations, including HIPAA compliance. All patient health information is encrypted, anonymized where appropriate, and handled with the highest level of security protocols to ensure patient confidentiality and data integrity.
SmartVisSolution provides comprehensive training programs, including online tutorials, webinars, and on-site demonstrations, to ensure physicians and their staff can effectively utilize the system. Ongoing technical support and clinical guidance are also available through dedicated support channels.

Related Tools

DeepMind (Google)
Google DeepMind
Clinical Decision Support & Reference
AlphaFold is an AI system developed by DeepMind (Google) that accurately predicts protein structures and their interactions, significantly accelerating biological and medical research.
Tempus AI
Tempus AI
Clinical Decision Support & Reference
Tempus ECG-AI Platform uses artificial intelligence to analyze electrocardiogram data, offering advanced insights for cardiovascular diagnosis and management.
Cortex
Cortex
Clinical Decision Support & Reference
Cortex Workspace is a secure, HIPAA-compliant AI platform designed to streamline healthcare workflows and enhance decision-making for physicians.
SureMediks ProView
SureMediks (Rasimo Systems, LLC)
Clinical Decision Support & Reference
SureMediks is an AI-powered clinical decision support and metabolic health platform that automates care workflows for specialists, providing AI-generated patient summaries, automated chart review, and real-time biometric alerts.
SOAP Health
SOAP Health
Clinical Decision Support & Reference
SOAP Health is a Florida-based startup transforming patient intake with AI-powered diagnosis, offering a comprehensive solution that improves diagnosis accuracy and empowers patients and physicians.
Oxipit ChestLink
Oxipit (part of Sectra group)
Clinical Decision Support & Reference
Oxipit ChestLink is the world's first CE Class IIb-certified autonomous AI application for healthy chest X-ray reporting, capable of identifying normal studies with 99.9% sensitivity. It automates the reporting of normal chest X-rays, reducing radiologist workload and improving efficiency.

See all Clinical Decision Support & Reference tools →

Suggest an Edit → | Last Verified: 2026-07-02 | First Added: 2026-07-02
AI Tool Finder
AI-powered search. Results may not be comprehensive.